About
The Oncidium foundation is a non-profit, public-benefit organization dedicated to advancing radioligand therapy for cancer care worldwide.
We focus on education, awareness, and advocating for equitable access to treatment. Through our initiatives, we bridge care gaps and build an ecosystem that supports people living with cancer, regardless of geographical or financial barriers, offering hope for an improved quality of life.
Together, let’s spread the word, better, faster.
Mission
& vision
We are striving toward equal access to radioligand therapy for cancer care for everyone, everywhere.
In the field of Nuclear medicine for cancer therapy, the concept of Radiotheranostics is just beginning to gain momentum in demonstrating its potential with the recent market launch of the first approved products. However, many patients and non-nuclear practitioners remain unaware of the existence and benefits of this technique. Therefore, raising awareness and advancing global access is a key to enhancing their development globally.
Through our three pillars: Improving Access, Advancing Education, and Building Hope, we are helping to transform cancer care and make radioligand therapy more accessible worldwide.
Key pillars
The Oncidium foundation is a worldwide hub connecting patients, practitioners and experts in the Nuclear medicine field, and focuses its mission on three main pillars:
Access
At the Oncidium foundation, we aim to improve ACCESS to radiotheranostics all around the world for patients, no matter their situation, and provide support to the healthcare professionals.
Education
We work on providing both patients & healthcare practitioners with essential knowledge. EDUCATION and awareness are essential, as everyone deserves access to the resources they need for informed decision-making.
Hope
We aspire to be a supportive bridge fostering collaboration and connections across all actors, bringing HOPE for patients when other treatments are not an option.
Before believing in the foundation, I strongly believe in the technology. But for a technology to be accepted by the largest number, one has first to push and develop this message to the largest number. Therefore, I believe in the important role of a foundation that can promote a technology with anincredible potential that will benefit this large number.
Meet
our Team
Based in Belgium, the foundation counts more than 16 dedicated staff members. It brings a diverse range of profiles, all united by sharing a common goal: Helping people living with cancer.
Meet our
ambassadors
Passionate advocates based in 70 countries, they help spread awareness, provide support, and build connections within local communities, bringing our global mission directly to those who need it the most.
Recognizing our committed philanthropists
behind the launch of the Oncidium foundation
The Oncidium foundation would not be able to continue the work it does or accomplish the achievements it has made without the generosity of its supporters. We would like to show our deep appreciation to our initial benefactors, that believed in the foundation, and thus, enabling the shift from being “just a cutting-edge idea” to a concrete and functional organization.
As the field of Nuclear medicine grows in importance, there is a need for patient advocacy groups that are able to build awareness of the field and connect patients to treatment options. I have always admired the vision of the Oncidium foundation and as an early participant in the creation of the foundation with Richard Zimmermann, I wanted to help deliver on the mission.
Having been in the field of Nuclear medicine for over two decades, I witnessed first-hand Radionuclide therapy gaining momentum worldwide, and felt the need to contribute to this worthy cause, by giving a voice to the Oncidium foundation. Given that the public still doesn’t have a clear understanding of its advantages, I believe that what the Oncidium foundation has been doing with endeavor can fill the current breach and takes us one step further to reach our common goal.
Why
Oncidium?
Orchids are plants that have reached the highest level of evolution in the plant kingdom. Oncidium is an orchid genus which refers to the callus at the lower lip of the flower and is derived from the Greek word “onkos”, meaning “tumor” and an indirect reference to cancer (Oncology).
An easy parallel can be made with Radiotheranostics which are drugs that have reached the highest level of development in the drug manufacturing world.
